TotalMarketCap

Context Therapeutics

CNTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$17.191 M

$0.19 -8.06%

Close of 6 Nov 2026

As of 6 Nov 2026, Context Therapeutics (CNTX) has a market capitalization of $17.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$36.1M

Loss-making

Shares outstanding

91,879,177

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #389Quantum BiopharmaQNTM$17.8M
  2. #390Akari TherapeuticsAKTX$17.5M
  3. #391Context TherapeuticsCNTX$17.2M
  4. #392Pasithea TherapeuticsKTTA$16.8M
  5. #393NewcelXNCEL$16.4M

What if Context Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$307,326.15

Per share 1,642,577× higher

Bitcoin $1.53T

$16,628.88

Per share 88,877× higher

Apple $5.02T

$54,591.07

Per share 291,775× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Context Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.